Literature DB >> 3972386

Incidence and significance of intrarenal vasculopathies in patients with systemic lupus erythematosus.

T Tsumagari, S Fukumoto, M Kinjo, K Tanaka.   

Abstract

A clinicopathologic autopsy study of the vascular changes in the kidneys of 100 patients with systemic lupus erythematosus was undertaken. Necrotizing arteritis was found in seven patients, mucinous intimal thickening in nine, onion-skin intimal thickening in two, and renal vein thrombosis in two. Active necrotizing arteritis was present most frequently in the arterioles and interlobular arteries, with healing necrotizing arteritis predominating in the arcuate and interlobar arteries. These events were closely related to the activity of glomerular lesions, and immunologic vascular injury seemed to be the causative factor. Rapidly progressive renal failure and severe hypertension had characterized the clinical courses of the patients. Mucinous intimal thickening, present in the arterioles and interlobular arteries, had been accompanied by accelerated hypertension. Although dialysis or accelerated hypertension may have been causes, other factors, including glucocorticoid therapy, must be considered. In one patient with class II lupus nephritis, renal vein thrombosis was considered the cause of the nephrotic syndrome. These vasculopathies, often detected in patients with lupus at autopsy, seem to alter the clinical course.

Entities:  

Mesh:

Year:  1985        PMID: 3972386     DOI: 10.1016/s0046-8177(85)80212-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Rapidly progressive lupus nephritis and concomitant thrombotic microangiopathy.

Authors:  Chems Gharbi; Edward Bourry; Philippe Rouvier; Sabria Hacini; Ahmed Letaief; Alain Baumelou; Hassane Izzedine
Journal:  Clin Exp Nephrol       Date:  2010-06-11       Impact factor: 2.801

2.  Renal thrombotic microangiopathy associated to worse renal prognosis in Lupus Nephritis.

Authors:  Fernando Louzada Strufaldi; Precil Diego Miranda de Menezes Menezes Neves; Cristiane Bitencourt Dias; Luis Yu; Viktoria Woronik; Livia Barreira Cavalcante; Denise Maria Avancini Costa Malheiros; Lectícia Barbosa Jorge
Journal:  J Nephrol       Date:  2021-02-11       Impact factor: 3.902

Review 3.  Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.

Authors:  Maria Izabel de Holanda; Luis Cristóvão Pôrto; Teresa Wagner; Luis Fernando Christiani; Lilian M P Palma
Journal:  Clin Rheumatol       Date:  2017-09-13       Impact factor: 2.980

Review 4.  Management of Severe Refractory Systemic Lupus Erythematosus: Real-World Experience and Literature Review.

Authors:  Huaxia Yang; Huazhen Liu; Ziyue Zhou; Lidan Zhao; Yunyun Fei; Hua Chen; Fengchun Zhang; Xuan Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-07       Impact factor: 8.667

5.  Systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis: An emerging overlap syndrome with cutaneous manifestations.

Authors:  Paul Curtiss; Tracey Liebman; Ciril Khorolsky; Nooshin Brinster; Jenna Beasley; Kristen Lo Sicco
Journal:  JAAD Case Rep       Date:  2018-05-07

6.  The spectrum of renal thrombotic microangiopathy in lupus nephritis.

Authors:  Di Song; Li-hua Wu; Feng-mei Wang; Xiao-wei Yang; Di Zhu; Min Chen; Feng Yu; Gang Liu; Ming-hui Zhao
Journal:  Arthritis Res Ther       Date:  2013-01-15       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.